/sites/default/files/2026-09/69478_field_list_cover_mauri8449_a_hand_of_a_doctor_with_glove_touching_a_virtual_co_0675fc00-2c39-41f4-a7e5-91e65df6809f_2_0.png
Guarda
10:40 - 11:50
TAVOLA ROTONDA SULL'HTA COME STRUMENTO PER ATTRARRE INVESTIMENTI PRIVATI NELL'INNOVAZIONE BIOHIGHTECH E AI IN FVG
Moderatore
10:40
Dott.ssa Roberta Terpin
Investment Manager Friulia S.p.A
Co-moderatore
10:50
Dott.ssa Elisabetta Borello
Co-Founder - Bio4Dreams S.p.A. - Milano
Relatori
11:00
Dott. Gabriele Bellon
Director - Banca di Credito Cooperativo Venezia Giulia - Trieste
11:10
Dott. Antonio Boccia
Head of Equity Capital Markets CFO SIM – Milano
11:20
Dott. Antonio Salera (da confermare)
Senior Research Analyst - Generali Asset Management
11:30
Ing. Floriana Vitale
Director Advisory & Capital Markets / Equity Partner, Irtop Consulting
11:40
Ing. Diego Bravar
CEO of Biovalley Partners S.p.A.